Inari Shares Skyrocket

Inari Shares Skyrocket As Stryker Will Acquire Medical Device Maker for $4.9B
Key Takeaways Shares of Inari Medical surged Monday afternoon and again Tuesday morning as reports of an imminent acquisition by Stryker turned into reality.Stryker will acquire Inari in an all-cash deal for $80 per share,
Stryker agrees to acquire Inari Medical for $4.9bn
Stryker has entered a definitive agreement to acquire complete issued and outstanding shares of Inari Medical’s common stock for $80 per share in cash, which equates to a total equity value of nearly $4.9bn. Inari is poised to enhance Stryker's footprint in the peripheral vascular sector, particularly in the venous thromboembolism (VTE) market.
Stryker Buying Inari Medical in $4.9B Deal to Boost Vascular Business
Medical device maker Stryker said it has reached a deal to acquire Inari Medical for $80 per share in cash, representing an approximate value of $4.9 billion.
Device maker Stryker strikes $4.9 billion deal for Inari Medical
By Anirban Sen NEW YORK (Reuters) -Medical-device maker Stryker on Monday agreed to acquire Inari Medical, which makes devices that treat patients with venous diseases, in an all-cash deal worth $4.9 billion.
Stryker to Acquire Inari Medical in Deal Valued at $4.9 Billion
Inari makes mechanical thrombectomy solutions designed to treat peripheral vascular diseases. Stryker said the deal would be complementary to its neurovascular business.
Stryker to acquire Inari Medical for $4.9B
Stryker said its planned acquisition of Inari Medical would strengthen its position in the peripheral vascular market.
Stryker Stock Falls Despite the Agreement to Acquire Inari Medical
Stryker Corporation SYK recently inked a definitive agreement to acquire all the issued and outstanding shares of common stock of Inari Medical, Inc. NARI for $80 per share in cash, representing a total fully diluted equity value of approximately $4.
Inari Medical soars on Stryker acquisition
Inari Medical Inc (NASDAQ:NARI) shares surged sharply after Stryker (NYSE:SYK) announced that it would acquire the medical device maker in an all-cash deal valued at $4.9 billion The acquisition strengthens Stryker’s position
Stryker to Buy Inari Medical in $4.9 Billion Deal
Stryker (SYK) agreed to acquire medical technology maker Inari Medical (NARI) in an all-cash deal worth roughly $4.9 billion as the company looks to boost its neurovascular and endovascular segments.
Cambridge agtech startup Inari raises equity at $2.17 billion valuation
Massachusetts agtech startup Inari Agriculture Inc. said it raised $144 million of new equity at a $2.17 billion valuation, a ...
Ag Funder News2d
Seed gene-editing startup Inari eyes commercialization with $144m round: ‘It puts us in a robust financial position’
Seed gene-editing startup Inari has completed a $144 million Series G round, bringing its cumulative funding to $720 million.
Inari raises $144M as Corteva lawsuit proceeds
Cambridge-based seed design company Inari Agriculture raised one of the first late-stage venture rounds of 2025.
Analysts Offer Insights on Healthcare Companies: Cencora (COR) and Inari Medical (NARI)
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Cencora (COR – Research Report) and Inari ...
Ag Funder News6h
The Week in AgriFoodTech: India’s Botanic Healthcare bags $29m, Fermata secures $10m, Plenty facing value cut
Agriculture-focused data science company Fermata secured $10 million while vertical farming company Plenty faces a value cut.
5 Things to Know Before the Stock Market Opens
U.S. stock futures are little changed after indexes were mixed Monday; Nvidia stock adds to all-time high after CEO comments; ...